Clinical Research
Peer-reviewed evidence from JAMA, NEJM, and Health Affairs. Synthesized for care teams, not just academic readers. Because better evidence leads to better outcomes across the continuum.
Five Research Domains
The evidence categories most relevant to clinicians and operators across acute, post-acute, and home health settings.
Clinical Evidence & Trials
Phase 3 results, randomized controlled trials, and systematic reviews that change clinical practice. Curated for care teams managing complex patients across settings.
Patient Safety Research
Hospital-acquired infections, medication errors, fall prevention, and adverse event surveillance. Research that informs quality improvement and accreditation.
Care Transitions Science
Readmission research, discharge protocol studies, and cross-setting care coordination evidence. Directly relevant to discharge planners and post-acute operators.
Health Equity Studies
Disparities in access, outcomes, and care quality across demographic and geographic lines. Research that surfaces systemic gaps and informs policy and program design.
Technology Outcomes Research
Peer-reviewed evidence on AI diagnostic accuracy, EHR implementation outcomes, telehealth efficacy, and device performance in real-world clinical settings.
Click any domain to filter the live research feed below.
Research Funding Landscape
$96B
Pharma Industry R&D
PhRMA member companies, 2023 — most recent reported
$47.5B
NIH Annual Budget
FY 2026 enacted · +1.0% vs FY 2025
$321M
BRAIN Initiative (NIH)
FY 2025 allocation · 10-year program (2014–2034)
593K+
Registered Clinical Studies
ClinicalTrials.gov as of July 2026
NIH Budget by Institute
FY 2026 enacted — $47.5B total across 27 institutes & centers
U.S. Research Funding Sources
Total ~$170B (directional estimate) — industry, federal & academic
BRAIN Initiative
$321M NIH allocation in FY 2025 (down ~20% from FY 2024 as 21st Century Cures funding ramps down), mapping neural circuits through 2034.
FY 2026 Budget Update
Congress enacted the FY 2026 NIH appropriation at $47.5B (+1.0% vs FY 2025), rejecting the administration's proposed restructuring and deep cuts. With ARPA-H ($1.5B), federal biomedical research funding totals $48.9B.
Funding-sources pie is a directional estimate anchored to verified NIH and PhRMA figures.
Doctor-Led. Evidence-Based.
NewsHX surfaces peer-reviewed research from the highest-impact journals in medicine. Articles link directly to source publications. We do not paraphrase or interpret study conclusions — summaries reflect the authors' published abstracts. Always read the full paper before applying findings in clinical practice.